Investigating how certain small RNAs affect T-cell leukemia treatment
Exploring microRNA degradation in T-cell acute lymphoblastic leukemia
['FUNDING_R01'] · UNIVERSITY OF FLORIDA · NIH-11059702
This study is looking at how tiny molecules called microRNAs affect treatment for T-cell acute lymphoblastic leukemia (T-ALL) and aims to find new ways to make chemotherapy work better for patients by understanding how a specific mRNA interacts with these microRNAs when treated with a common drug.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF FLORIDA (nih funded) |
| Locations | 1 site (GAINESVILLE, UNITED STATES) |
| Trial ID | NIH-11059702 on ClinicalTrials.gov |
What this research studies
This research focuses on understanding the role of microRNAs in T-cell acute lymphoblastic leukemia (T-ALL) and how their degradation can influence cancer treatment. The study examines how a specific mRNA, BIM, can degrade two microRNAs (miR-221/222) when T-ALL cells are treated with a common chemotherapy drug, dexamethasone. By exploring this unexpected interaction, the research aims to develop new strategies for enhancing the effectiveness of chemotherapy in T-ALL patients. Additionally, the project will create a method to identify other mRNAs that may also induce microRNA degradation in T-ALL samples.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with T-cell acute lymphoblastic leukemia who are undergoing chemotherapy.
Not a fit: Patients with other types of leukemia or those not receiving chemotherapy may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved chemotherapy outcomes for patients with T-cell acute lymphoblastic leukemia.
How similar studies have performed: While the specific approach of mRNA-induced microRNA degradation is novel, similar research has shown promise in understanding gene regulation in cancer.
Where this research is happening
GAINESVILLE, UNITED STATES
- UNIVERSITY OF FLORIDA — GAINESVILLE, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: XIE, MINGYI — UNIVERSITY OF FLORIDA
- Study coordinator: XIE, MINGYI
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.